Works matching IS 17501326 AND DT 2010 AND VI 5


Results: 61
    1
    2
    3
    4
    5

    Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 58, doi. 10.1186/1750-1326-5-58
    By:
    • Kegel, Kimberly B.;
    • Sapp, Ellen;
    • Alexander, Jonathan;
    • Reeves, Patrick;
    • Bleckmann, Dorothee;
    • Sobin, Linsday;
    • Masso, Nicholas;
    • Valencia, Antonio;
    • Jeong, Hyunkyung;
    • Krainc, Dimitri;
    • Palacino, James;
    • Curtis, Daniel;
    • Kuhn, Rainer;
    • Betschart, Claudia;
    • Sena-Esteves, Miguel;
    • Aronin, Neil;
    • Paganetti, Paolo;
    • DiFiglia, Marian
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 45, doi. 10.1186/1750-1326-5-45
    By:
    • O'Leary, III., John C.;
    • Qingyou Li;
    • Marinec, Paul;
    • Blair, Laura J.;
    • Congdon, Erin E.;
    • Johnson, Amelia G.;
    • Jinwal, Umesh K.;
    • Koren, III., John;
    • Jones, Jeffrey R.;
    • Kraft, Clara;
    • Peters, Melinda;
    • Abisambra, Jose F.;
    • Duff, Karen E.;
    • Weeber, Edwin J.;
    • Gestwicki, Jason E.;
    • Dickey, Chad A.
    Publication type:
    Article
    19
    20

    MOLECULAR NEURODEGENERATION.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 43, doi. 10.1186/1750-1326-5-43
    By:
    • Koprich, James B.;
    • Johnston, Tom H.;
    • Reyes, M. Gabriela;
    • Xuan Sun;
    • Brotchie, Jonathan M.
    Publication type:
    Article
    21
    22
    23

    The biochemical aftermath of anti-amyloid immunotherapy.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 39, doi. 10.1186/1750-1326-5-39
    By:
    • Maarouf, Chera L.;
    • Daugs, Ian D.;
    • Kokjohn, Tyler A.;
    • Kalback, Walter M.;
    • Patton, R. Lyle;
    • Luehrs, Dean C.;
    • Masliah, Eliezer;
    • Nicoll, James A. R.;
    • Sabbagh, Marwan N.;
    • Beach, Thomas G.;
    • Castaño, Eduardo M.;
    • Roher, Alex E.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 26, doi. 10.1186/1750-1326-5-26
    By:
    • Fox, Jonathan H.;
    • Connor, Teal;
    • Chopra, Vanita;
    • Dorsey, Kate;
    • Kama, Jibrin A.;
    • Bleckmann, Dorothee;
    • Betschart, Claudia;
    • Hoyer, Daniel;
    • Frentzel, Stefan;
    • DiFiglia, Marian;
    • Paganetti, Paolo;
    • Hersch, Steven M.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    ApoE mimetic peptide decreases AΒ production in vitro and in vivo.

    Published in:
    Molecular Neurodegeneration, 2010, v. 5, p. 16, doi. 10.1186/1750-1326-5-16
    By:
    • Minami, S. Sakura;
    • Cordova, Antoinette;
    • Cirrito, John R.;
    • Tesoriero, Joseph A.;
    • Babus, Lenard W.;
    • Davis, Gary C.;
    • Dakshanamurthy, Sivanesan;
    • Turner, R. Scott;
    • Pak, Daniel T. S.;
    • Rebeck, G. William;
    • Paige, Mikell;
    • Hyang-Sook Hoe
    Publication type:
    Article
    45
    46
    47
    48
    49
    50